The post hoc analysis of postintervention follow-up of calcium and vitamin D (CaD) supplements suggested reduced cancer mortality and increased cardiovascular disease (CVD) mortality. The multicenter trial across the US included 36 282 postmenopausal women randomized 1:1 to 1000 mg of calcium carbonate (400 mg of elemental calcium) with 400 IU of vitamin D3 daily or placebo for 7 years. For women assigned to CaD vs placebo, a 7% reduction in cancer mortality was observed with a median cumulative follow-up of 22.3 years (1817 vs. 1943 deaths; hazard ratio [HR], 0.93), along with a 6% increase in CVD mortality (2621 vs. 2420 deaths; HR, 1.06). There was no effect on all-cause mortality (7834 vs. 7748 deaths; HR, 1.00). Estimates for cancer incidence varied widely when stratified by whether participants reported supplement use before randomization, whereas estimates on mortality did not vary, except for CVD mortality. The findings provide evidence of long-term effects of CaD supplementation on mortality in postmenopausal women. Source: https://www.acpjournals.org/
A Spanish secondary prevention study suggested that Mediterranean diet might reduce neutrophil levels and slow…
Top 10 key takeaway points of the report of the American College of Cardiology Solution…
A UK device-based prospective study suggested that irregular sleep was associated with higher risk of…
A Chinese parallel design, randomized clinical trial showed that the incidence of major cardiovascular events…
A study comparing UK adults conceived just before or after sugar rationing ended found that…
A Chinese nationwide case-crossover study revealed that lower temperatures were associated with higher risks of…
This website uses cookies.